Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study
出版年份 2021 全文链接
标题
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study
作者
关键词
-
出版物
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-04-01
DOI
10.1007/s10072-021-05216-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer Risk for Fingolimod, Natalizumab, and Rituximab in MS Patients
- (2020) Peter Alping et al. ANNALS OF NEUROLOGY
- Advances in oral immunomodulating therapies in relapsing multiple sclerosis
- (2020) Tobias Derfuss et al. LANCET NEUROLOGY
- Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
- (2020) Esther Melamed et al. Frontiers in Immunology
- Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis
- (2019) Babak Soleimani et al. DRUG SAFETY
- Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort
- (2019) Emanuele D'Amico et al. Frontiers in Neurology
- Disease-modifying treatments for early and advanced multiple sclerosis
- (2018) Gavin Giovannoni CURRENT OPINION IN NEUROLOGY
- ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) X. Montalban et al. EUROPEAN JOURNAL OF NEUROLOGY
- Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
- (2018) Alexander Rae-Grant et al. NEUROLOGY
- Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs
- (2018) Christine Lebrun et al. CNS DRUGS
- Estimates of cancer burden in Italy
- (2018) Silvia Rossi et al. TUMORI
- The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
- (2017) Gabriel Pardo et al. JOURNAL OF NEUROLOGY
- Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study
- (2017) Xavier Moisset et al. PLoS One
- Malignancies after mitoxantrone for multiple sclerosis
- (2016) Mathias Buttmann et al. NEUROLOGY
- The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study
- (2016) Emanuele D’Amico et al. PLoS One
- Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial
- (2014) Luca Massacesi et al. PLoS One
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Cancer and multiple sclerosis in the era of disease-modifying treatments
- (2011) Christine Lebrun et al. JOURNAL OF NEUROLOGY
- Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis
- (2008) Christine Lebrun et al. Multiple Sclerosis Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now